Scholarlink

Background <p>Dyslipidemia constitutes one of the foremost metabolic abnormalities contributing to cardiovascular morbidity and mortality. Washed microbiota transplantation (WMT), a refined form of fecal microbiota transplantation, has emerged as a novel therapeutic option targeting gut-liver axis dysregulation. This systematic review and meta-analysis, registered on PROSPERO (CRD42025645142), evaluated the efficacy of WMT in modulating lipid profile parameters. A comprehensive search was conducted across PubMed, Scopus, EMBASE, CENTRAL, Google Scholar, and ClinicalTrials.gov for studies assessing WMT effects on total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG). Eligible studies included adults receiving WMT without concurrent lipid-lowering or microbiota-modifying therapies. Data were pooled using random-effects meta-analysis. MINORS tool was used to assess methodological quality.</p> Results <p>Seven studies encompassing 1,163 participants were included. Across all study groups, WMT significantly reduced short-term TC (MD = –0.18; 95% CI –0.32 to –0.03) and long-term TG (MD = –0.08; 95% CI –0.11 to –0.05). LDL-C showed a significant long-term decrease (MD = –0.24; 95% CI –0.46 to –0.02), whereas HDL-C changes were non-significant overall. In participants with baseline hyperlipidemia, WMT consistently improved TC (short- and medium-term) and HDL-C (short-term), while effects on LDL and&#xa0;TG remained non-significant. Meta-regression demonstrated that higher baseline TC, HDL-C, and TG levels predicted greater post-WMT improvements (all p &lt; 0.01). The overall certainty of evidence was low for most outcomes due to heterogeneity and observational study design.</p> Conclusion <p>WMT may improve lipid profiles, especially in patients with elevated baseline lipids, offering a microbiota-based adjunct for dyslipidemia management. High-quality RCTs and optimized protocols are needed to confirm long-term efficacy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Targeting lipid disorders with washed microbiota transplantation in statin-free adults: a systematic review and meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月12日

查看全文
  • Mostafa Tarek Abdullatif,
  • Mohamad Ashraf Salaheldin,
  • Adham Yasser Abdelmonem Elhashash,
  • Abdullah Tawfik Aly,
  • Selim Ahmed Eliwa,
  • Abdelrahman Mahmoud Abdelhamid,
  • Soha Aly Elmorsy,
  • Omnia Azmy Nabeh

摘要

Background

Dyslipidemia constitutes one of the foremost metabolic abnormalities contributing to cardiovascular morbidity and mortality. Washed microbiota transplantation (WMT), a refined form of fecal microbiota transplantation, has emerged as a novel therapeutic option targeting gut-liver axis dysregulation. This systematic review and meta-analysis, registered on PROSPERO (CRD42025645142), evaluated the efficacy of WMT in modulating lipid profile parameters. A comprehensive search was conducted across PubMed, Scopus, EMBASE, CENTRAL, Google Scholar, and ClinicalTrials.gov for studies assessing WMT effects on total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG). Eligible studies included adults receiving WMT without concurrent lipid-lowering or microbiota-modifying therapies. Data were pooled using random-effects meta-analysis. MINORS tool was used to assess methodological quality.

Results

Seven studies encompassing 1,163 participants were included. Across all study groups, WMT significantly reduced short-term TC (MD = –0.18; 95% CI –0.32 to –0.03) and long-term TG (MD = –0.08; 95% CI –0.11 to –0.05). LDL-C showed a significant long-term decrease (MD = –0.24; 95% CI –0.46 to –0.02), whereas HDL-C changes were non-significant overall. In participants with baseline hyperlipidemia, WMT consistently improved TC (short- and medium-term) and HDL-C (short-term), while effects on LDL and TG remained non-significant. Meta-regression demonstrated that higher baseline TC, HDL-C, and TG levels predicted greater post-WMT improvements (all p < 0.01). The overall certainty of evidence was low for most outcomes due to heterogeneity and observational study design.

Conclusion

WMT may improve lipid profiles, especially in patients with elevated baseline lipids, offering a microbiota-based adjunct for dyslipidemia management. High-quality RCTs and optimized protocols are needed to confirm long-term efficacy.